Unlimited Access. Try it Today! Your First 10 Days Always $0.99

Topics

Animal Research
Baltimore's Profectus marks key step in race for Ebola vaccine
Baltimore's Profectus marks key step in race for Ebola vaccine

An Ebola vaccine being developed by Baltimore company Profectus BioSciences is effective against the strain of the virus that has ravaged West Africa, research to be published Thursday suggests — a milestone the company says is a first in the race to prevent outbreaks of the deadly disease. While other leading vaccine candidates have progressed to human trials in Africa, published data on the protection they provide is based on tests exposing animals to a relatively mild laboratory version of the Ebola virus, or strains from previous outbreaks. But Profectus' vaccine successfully shielded primates from a potent strain virtually identical to the one that has infected more than...

Loading

41°